Category: Regulatory Updates

The Regulatory Updates category provides timely coverage of new guidelines, draft revisions, and official communications from authorities such as the EMA, FDA, ICH, USP, and Ph. Eur. It highlights regulatory changes that affect GMP operations, product development, and quality systems.

Each update is presented with context, showing what it means for manufacturers, QA/RA professionals, Qualified Persons, and supply chain leaders. Topics range from revisions to GMP chapters and data integrity expectations to draft guidance on testing and validation.

If you don’t find what you are looking for, try using a different term or contact us.

Topical Ophthalmic Drug Products

FDA Releases New Draft Guidance on Quality Considerations for Topical Ophthalmic Drug Products

Explore the FDA's latest draft guidance for top-notch quality in topical ophthalmic drug products. Stay informed on key considerations for...
Swissmedicines Inspectorate

SwissMedicines Inspectorate: Interpretation of GMP Annex 1 [2022]

Swissmedicines Inspectorate interprets the 2022 GMP Annex 1 guidelines, offering crucial insights into pharmaceutical manufacturing quality. Stay informed with GMP...

BECOME A GMP INSIDER

Stay in touch and be the first to get the latest GMP News!